IS4617A - Use of alendronate to prevent osteoporosis - Google Patents

Use of alendronate to prevent osteoporosis

Info

Publication number
IS4617A
IS4617A IS4617A IS4617A IS4617A IS 4617 A IS4617 A IS 4617A IS 4617 A IS4617 A IS 4617A IS 4617 A IS4617 A IS 4617A IS 4617 A IS4617 A IS 4617A
Authority
IS
Iceland
Prior art keywords
alendronate
prevent osteoporosis
osteoporosis
prevent
Prior art date
Application number
IS4617A
Other languages
Icelandic (is)
Inventor
J. Yates Ashley
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of IS4617A publication Critical patent/IS4617A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IS4617A 1995-06-02 1997-11-19 Use of alendronate to prevent osteoporosis IS4617A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45819595A 1995-06-02 1995-06-02
PCT/US1996/007912 WO1996038156A1 (en) 1995-06-02 1996-05-29 Use of alendronate for the prevention of osteoporosis

Publications (1)

Publication Number Publication Date
IS4617A true IS4617A (en) 1997-11-19

Family

ID=23819759

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4617A IS4617A (en) 1995-06-02 1997-11-19 Use of alendronate to prevent osteoporosis

Country Status (21)

Country Link
EP (1) EP0828496A1 (en)
JP (1) JPH10506648A (en)
KR (1) KR19990022436A (en)
CN (1) CN1192685A (en)
AU (1) AU709196B2 (en)
BG (1) BG63103B1 (en)
BR (1) BR9609020A (en)
CA (1) CA2222318A1 (en)
CZ (1) CZ381197A3 (en)
EA (1) EA000677B1 (en)
EE (1) EE03306B1 (en)
HU (1) HUP9900659A3 (en)
IL (1) IL118422A0 (en)
IS (1) IS4617A (en)
NO (1) NO975527L (en)
NZ (1) NZ308935A (en)
PL (1) PL323669A1 (en)
SK (1) SK159597A3 (en)
TR (1) TR199701482T1 (en)
WO (1) WO1996038156A1 (en)
ZA (1) ZA964465B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
SE9901272D0 (en) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
KR100317935B1 (en) * 1999-10-20 2001-12-22 유승필 Pharmaceutical compositions and preparations for treatment of metabolic bone disease
EP1392325B1 (en) * 2001-05-02 2006-06-21 Novartis AG Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
JP2010043119A (en) * 2009-10-16 2010-02-25 Gador Sa Composition for preventing and/or treating bone metabolic disease, method of preparing the same and use thereof
KR102472749B1 (en) * 2022-01-18 2022-12-02 주식회사 위엔씨 Manufacturing method of adsorption material with harmful gas removal antibacterial and deodorizing functions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366965A (en) * 1993-01-29 1994-11-22 Boehringer Mannheim Gmbh Regimen for treatment or prophylaxis of osteoporosis
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations

Also Published As

Publication number Publication date
JPH10506648A (en) 1998-06-30
NO975527D0 (en) 1997-12-01
BG63103B1 (en) 2001-04-30
CN1192685A (en) 1998-09-09
NZ308935A (en) 2000-07-28
TR199701482T1 (en) 1998-03-21
IL118422A0 (en) 1996-09-12
KR19990022436A (en) 1999-03-25
EE03306B1 (en) 2000-12-15
CA2222318A1 (en) 1996-12-05
AU709196B2 (en) 1999-08-26
EA000677B1 (en) 2000-02-28
AU5882496A (en) 1996-12-18
ZA964465B (en) 1996-12-11
WO1996038156A1 (en) 1996-12-05
BG102060A (en) 1998-07-31
HUP9900659A3 (en) 2002-12-28
EA199700449A1 (en) 1998-06-25
HUP9900659A2 (en) 2001-04-28
BR9609020A (en) 1999-07-06
EP0828496A1 (en) 1998-03-18
NO975527L (en) 1997-12-01
CZ381197A3 (en) 1998-06-17
PL323669A1 (en) 1998-04-14
SK159597A3 (en) 1998-06-03

Similar Documents

Publication Publication Date Title
FR2729849B1 (en) ADHESIVE PLASTER
DK0770615T3 (en) Process for the preparation of dihalogenazolopyrimidines
ID19439A (en) IMPROVEMENT OF ORGANIC COMPOUNDS OR RELATED
NO952986L (en) Device for the mutual attachment of two devices
IT1276799B1 (en) FORMULATIONS OF F-SILICONE
IS4617A (en) Use of alendronate to prevent osteoporosis
NO991569D0 (en) Liquid alendronate compounds
FI952707A0 (en) Preheater water preheater system
ID17424A (en) INHIBITION OF METALOPROTEASA MATRIX BY SUBSTITUTED FENETYL COMPOUNDS
IT1282786B1 (en) SELF-PERFORATING ANKLE
FIU950494U0 (en) Skaerverktyg Foer gypsum
DK0721929T3 (en) Process for the preparation of hydroxyalkoxybenzophenones
NO980862D0 (en) Zwitterinoforms of trovafloxacin
DE59601357D1 (en) New liquid formulations
DK0863874T3 (en) Process for the preparation of dioxoazabicyclohexanes
NO964685L (en) Isomization of equilin
KR960031589U (en) End Connection of Footpath Boundary Stone
PT761766E (en) ASYMPHETRIC COMPOUNDS OF TRIFENYLENEOXAZINE
DE29518364U1 (en) Walking aid
AT204U3 (en) FOOT SCRAPER
DE29510361U1 (en) Concrete sprayer
KR970000111U (en) 3rd phase transfer of the metropolitan equipment system
KR970010637U (en) Switchgear of water distributor
KR970015931U (en) Detachable shoes
KR960027282U (en) Spatula for construction painting